Agios Pharmaceuticals | AGIO - Capitalização De Mercado





Capitalização De Mercado Alterar Data
AbbVie USD 508.97B 46.71B 2026-11
Agios Pharmaceuticals USD 1.61B 598M 2026-11
Alnylam Pharmaceuticals USD 33.02B 7.17B 2026-09
Amgen USD 247.94B 20.06B 2026-11
Arrowhead Research USD 11.5B 2.72B 2026-06
Astellas Pharma JPY 4.78T 582.95B 2026-11
AstraZeneca USD 213.88B 23.43B 2026-11
Bayer EUR 52.42B 5.31B 2026-11
Biogen USD 33.38B 1.48B 2026-09
BioMarin Pharmaceutical USD 10.68B 936M 2026-11
Bristol-Myers Squibb USD 127.46B 9.81B 2026-09
Daiichi Sankyo JPY 5.22T 356.74B 2026-09
Eli Lilly USD 1.09T 40.33B 2026-09
Exelixis USD 19.82B 5.34B 2026-11
Gilead Sciences USD 184.82B 27.96B 2026-09
GlaxoSmithKline GBP 74.11B 6.03B 2026-09
Incyte USD 24.6B 1.95B 2026-09
Ionis Pharmaceuticals USD 5.75B 1.67B 2026-11
Merck USD 375.59B 17.09B 2026-11
Moderna USD 99.14B 22.26B 2026-11
Nektar Therapeutics USD 2.12B 1.26B 2026-03
Novartis USD 292.09B 51.5B 2026-09
Novartis USD 328.21B 54.92B 2026-11
Pfizer USD 165.12B 1.71B 2026-11
Roche Holding CHF 270B 3.66B 2026-06
Sarepta Therapeutics USD 1.65B 276M 2026-11
Vertex Pharmaceuticals USD 140.44B 7.93B 2026-11